PALI Stock Analysis: Buy, Sell, or Hold?
PALI - Palisade Bio, Inc. Common Stock
$1.94
0.10 (5.43%)
▲
5d:
+14.79%
30d:
-3.48%
90d:
+1.57%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When PALI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PALI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PALI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: PALI is currently trading at $1.94, which is considered slightly high relative to its 30-day fair value range of $1.74 to $2.00.
Technical Outlook: Technically, PALI is in a uptrend. Immediate support is located at $1.64, while resistance sits at $2.15. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: PALI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.71 (+400.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PALI is in a uptrend. Immediate support is located at $1.64, while resistance sits at $2.15. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: PALI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.71 (+400.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.74 -
$2.00
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 400.7% below Wall St target ($9.71)
Trading Range Analysis
30-Day Trading Range
$1.74 -
$2.00
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.64
Resistance Level
$2.16
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.26
Wall Street Target
$9.71
(+400.7%)
Share & Embed Analysis
Last updated: June 23, 2026 11:22 PM ET
Data refreshes hourly during market hours. Next update: 12:22 AM
Data refreshes hourly during market hours. Next update: 12:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PALI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
John David Finley
SELL
3896 shares
2026-02-12
Mitchell Lawrence Jones
SELL
1989 shares
2026-02-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
